Medicina,
Год журнала:
2020,
Номер
56(5), С. 237 - 237
Опубликована: Май 15, 2020
Cannabis
has
been
used
for
centuries
therapeutic
purposes.
In
the
last
century,
plant
was
demonized
due
to
its
high
abuse
liability
and
supposedly
insufficient
health
benefits.
However,
recent
decriminalization
policies
new
scientific
evidence
have
increased
interest
in
cannabis
potential
of
paved
way
release
marketing
authorizations
cannabis-based
products.
Although
several
synthetic
standardized
products
are
currently
available
on
market,
patients’
preferences
lean
towards
herbal
preparations,
because
they
easy
handle
self-administer.
A
literature
search
conducted
multidisciplinary
research
databases
international
agencies
or
institutional
websites.
Despite
growing
popularity
medical
cannabis,
little
data
is
chemical
composition
preparation
methods
extracts.
The
authors
hereby
report
most
common
presenting
their
indications,
routes
administration
recommended
dosages.
practical
helpful
guide
prescribing
doctors
provided,
including
suggested
posology,
titration
strategies
cannabinoid
amounts
preparations
obtained
from
different
sources
cannabis.
American Journal on Addictions,
Год журнала:
2019,
Номер
29(1), С. 9 - 26
Опубликована: Окт. 2, 2019
Background
and
Objectives
Cannabis
use
is
common
in
people
with
mood
anxiety
disorders
(ADs),
rates
of
problematic
are
higher
than
the
general
population.
Given
recent
policy
changes
favor
cannabis
legalization,
it
important
to
understand
how
cannabinoids
may
impact
these
disorders.
We
aimed
assess
effects
on
onset
course
depression,
bipolar
disorder,
ADs,
post‐traumatic
stress
disorder
(PTSD),
also
explore
therapeutic
potential
for
Methods
A
systematic
review
literature
was
completed.
The
PubMed®
database
from
January
1990
May
2018
searched.
included
longitudinal
cohort
studies,
all
studies
using
or
a
cannabinoid
as
an
active
intervention,
regardless
study
design.
Results
Forty‐seven
were
included:
32
reported
illness
onset,
nine
course,
six
therapeutics.
Cohort
varied
significantly
design
quality.
suggests
that
linked
poorer
clinical
PTSD,
but
this
finding
not
clear
depression
(ADs).
There
have
been
few
high‐quality
pharmaceuticals
settings.
Conclusions
Scientific
Significance
These
conclusions
limited
by
lack
well‐controlled
studies.
suggest
future
research
be
directed
toward
high‐quality,
prospective
populations
addition
controlled
constituents
populations.
(Am
J
Addict
2019;00:00–00)
Medicina,
Год журнала:
2020,
Номер
56(5), С. 237 - 237
Опубликована: Май 15, 2020
Cannabis
has
been
used
for
centuries
therapeutic
purposes.
In
the
last
century,
plant
was
demonized
due
to
its
high
abuse
liability
and
supposedly
insufficient
health
benefits.
However,
recent
decriminalization
policies
new
scientific
evidence
have
increased
interest
in
cannabis
potential
of
paved
way
release
marketing
authorizations
cannabis-based
products.
Although
several
synthetic
standardized
products
are
currently
available
on
market,
patients’
preferences
lean
towards
herbal
preparations,
because
they
easy
handle
self-administer.
A
literature
search
conducted
multidisciplinary
research
databases
international
agencies
or
institutional
websites.
Despite
growing
popularity
medical
cannabis,
little
data
is
chemical
composition
preparation
methods
extracts.
The
authors
hereby
report
most
common
presenting
their
indications,
routes
administration
recommended
dosages.
practical
helpful
guide
prescribing
doctors
provided,
including
suggested
posology,
titration
strategies
cannabinoid
amounts
preparations
obtained
from
different
sources
cannabis.
